ANDA 76519, held by Able Laboratories. Metronidazole.
As of Nov 21, 2026, ANDA 76519 (Metronidazole), held by Able Laboratories, was first approved by FDA on Jun 27, 2003, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 27, 2003 | Original application | Approved | None posted |
| Metronidazole250MG · tablet;oral | Metronidazole | Discontinued |
| Metronidazole500MG · tablet;oral | Metronidazole | Discontinued |
| Mar 28, 2005 | Supplement 3Labeling | Approved | None posted |
| Dec 16, 2003 | Supplement 1Labeling | Approved | None posted |
| Jun 27, 2003 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters